½ÃÀ庸°í¼­
»óǰÄÚµå
1379109

½Ä¹° Áö³ëŸÀÌÇÎ Àåºñ ½ÃÀå : ¼¼°è »ê¾÷ µ¿Çâ, Á¡À¯À², ±Ô¸ð, ¼ºÀå, ±âȸ ¹× ¿¹Ãø(2023-2028³â)

Plant Genotyping Equipment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: IMARC | ÆäÀÌÁö Á¤º¸: ¿µ¹® 142 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

°³¿ä

¼¼°è ½Ä¹° Áö³ëŸÀÌÇÎ Àåºñ ½ÃÀå ±Ô¸ð´Â 2022³â 6¾ï 8,600¸¸ ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. IMARC GroupÀº 2028³â±îÁö ½ÃÀå ±Ô¸ð°¡ 12¾ï 300¸¸ ´Þ·¯¿¡ ´ÞÇϰí, 2022-2028³â°£ 9.8%ÀÇ ¿¬Æò±Õ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óÇß½À´Ï´Ù. °í¼öÀÍ ÀÛ¹°¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ½Ä¹°ÀÇ ³»¼º ¹× ÀûÀÀ·Â Çâ»ó¿¡ ´ëÇÑ Çʿ伺 Áõ°¡, ³ó¾÷ÀÇ È£È²Àº ½ÃÀåÀ» ÁÖµµÇÏ´Â ÁÖ¿ä ¿äÀÎ Áß ÀϺÎÀÔ´Ï´Ù.

½Ä¹° À¯ÀüÇü ºÐ¼®Àº µð¿Á½Ã¸®º¸ÇÙ»ê(DNA) ¿°±â¼­¿­À» »ùÇà ¶Ç´Â ÂüÁ¶¿Í ºñ±³ ºÐ¼®ÇÏ¿© À¯ÀüÀû ÀÌÇØÀÇ Â÷À̸¦ ½Äº°ÇÏ´Â °úÁ¤ÀÔ´Ï´Ù. ¿µ¾ç°¡°¡ ³ô°í Áúº´°ú ȯ°æ ½ºÆ®·¹½º¿¡ °­ÇÑ ½Ä¹°À» °³¹ßÇϱâ À§ÇØ Â÷¼¼´ë ¿°±â¼­¿­ ºÐ¼®(NGS) ±â¼ú¿¡ ÀÇÁ¸Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ´Ù¾çÇÑ Á¾ÀÇ ´Ù¾ç¼º°ú ÁøÈ­ ¿¬±¸, »ý½Ä ¿øÁ¾ Ư¼ºÈ­ ¹× Á¾ÀÚ ¼øµµ ¿¬±¸, ¸¶Ä¿ Áö¿ø ¼±¹ß(MAS)¿¡µµ µµ¿òÀÌ µÇ°í ÀÖ½À´Ï´Ù. ÀÛ¹° ÇüÁú °³¹ß, Á¾ÀÚ Ç°Áú °ü¸® µî ´Ù¾çÇÑ ³ó¾÷ ¿¬±¸ ºÐ¾ß¿¡¼­ Ȱ¿ëµÇ°í ÀÖ½À´Ï´Ù. ´ÜÀÏ¿°±â´ÙÇü¼º(SNP) À¯ÀüÇü ºÐ¼® Àåºñ, ½Ç½Ã°£ ÁßÇÕÈ¿¼Ò¿¬¼â¹ÝÀÀ(PCR) Àåºñ, DNA ºÐ¼®±â, ¾×ü Çڵ鷯 µî ´Ù¾çÇÑ Àåºñ·Î ±¸ÇöÇÒ ¼ö ÀÖ½À´Ï´Ù. ½Ä¹° À¯ÀüÇü ºÐ¼® Àåºñ´Â ½Ä¹°ÀÇ À¯ÀüÀÚ ¸¶Ä¿¸¦ ºÐ¼®, ½Äº° ¹× Æò°¡ÇÏ´Â µ¥ »ç¿ëµË´Ï´Ù. ¶ÇÇÑ, ½Ä¹°ÀÇ À¯ÀüÀÚ¸¦ ºÐÀÚ ¼öÁØ¿¡¼­ º¯È­½ÃŰ°Å³ª ǰÁ¾ °³·® °úÁ¤¿¡¼­ ÅëÇÕÇÏ¿© ÀÛ¹° ¼öÈ®·®À» ÃËÁøÇÕ´Ï´Ù.

½Ä¹° Áö³ëŸÀÌÇÎ Àåºñ ½ÃÀå µ¿Çâ :

ÇöÀç ¼¼°è Àα¸ Áõ°¡·Î ÀÎÇØ °í¼öÀÍ ÀÛ¹°¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ´Â ³ó¾÷ÀÇ ¹ø¿µ°ú ÇÔ²² ½ÃÀå ¼ºÀåÀ» µÞ¹ÞħÇÏ´Â Áß¿äÇÑ ¿ä¼Ò Áß Çϳª°¡ µÇ¾ú½À´Ï´Ù. ¶ÇÇÑ, ¾ÈÁ¤ÀûÀÎ ³ôÀº ÀÛ¹° »ý»êÀ» º¸ÀåÇϱâ À§ÇØ ´Ù¾çÇÑ ¾ÇÁ¶°Ç¿¡ ´ëÇÑ ½Ä¹°ÀÇ ³»¼º°ú ÀûÀÀ·ÂÀ» Çâ»ó½ÃÄÑ¾ß ÇÒ Çʿ伺ÀÌ Áõ°¡Çϰí ÀÖ´Â °Íµµ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù. ÀÌ ¿Ü¿¡µµ º¹ÀâÇÑ ½Ä¹° ÇüÁú°ú °ü·ÃµÈ À¯ÀüÀû Ư¼º°ú ÀÌ·¯ÇÑ ÇüÁú¿¡ ´ëÇÑ ´Ù¾çÇÑ È¯°æ ¿äÀÎÀÇ ¿µÇâÀ» ÀÌÇØÇϱâ À§ÇÑ ½Ä¹° À¯ÀüÇüÁú ºÐ¼® Àåºñ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϸ鼭 ½ÃÀå¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¿øÇϴ ǥÇöÇü ÇüÁú°ú °ü·ÃµÈ º¯Á¾À» ½Äº°Çϱâ À§ÇÑ ½Ä¹° À¯ÀüÇüÁú ºÐ¼® ÀåºñÀÇ »ç¿ëÀÌ ¼¼°èÀûÀ¸·Î Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ´Â Çö´ë½Ä ³ó¹ýÀÇ µµÀÔ Áõ°¡¿Í ÇÔ²² ¾÷°è ÅõÀÚÀڵ鿡°Ô À¯¸®ÇÑ ¼ºÀå ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. ÀÌ ¿Ü¿¡µµ ¼öÈ®·®, ³»¼º, »ý¹°ÇÐÀû ¹× »ý¹°ÇÐÀû ½ºÆ®·¹½º¿¡ ´ëÇÑ ÀúÇ×¼º µî ½Ä¹° À¯ÀüÇüÀÇ °Åµ¿À» ÀÌÇØÇϱâ À§ÇÑ ½Ä¹° À¯ÀüÇü ºÐ¼® Àåºñ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó ½ÃÀå ¼ºÀåÀ» °­È­Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ³ôÀº ÇØÃæ ÀúÇ×¼º, ´õ ¸¹Àº ¼öÈ®·®, Çâ»óµÈ ½ºÆ®·¹½º ÀúÇ×¼º°ú °°Àº ´Ù¾çÇÑ ½Ä¹° Ư¼ºÀ» Çâ»ó½Ã۱â À§ÇØ SNP À¯ÀüÇüÁú ºÐ¼® Àåºñ ¹× Á¤·®Àû ÇüÁú À¯ÀüÀÚÁÂ(QTL)¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó ÁÁÀº ½ÃÀå Àü¸ÁÀ» Á¦°øÇÕ´Ï´Ù.

º» º¸°í¼­¿¡¼­ ´Ù·é ÁÖ¿ä Áú¹®µé

  • 2022³â ½Ä¹° Áö³ëŸÀÌÇÎ Àåºñ ¼¼°è ½ÃÀå ±Ô¸ð´Â?
  • 2023-2028³â ¼¼°è ½Ä¹° Áö³ëŸÀÌÇÎ Àåºñ ½ÃÀåÀÇ ¿¹»ó ¼ºÀå·üÀº?
  • ½Ä¹° Áö³ëŸÀÌÇÎ Àåºñ ¼¼°è ½ÃÀåÀ» ÁÖµµÇÏ´Â ÁÖ¿ä ¿äÀÎÀº?
  • Äڷγª19°¡ ¼¼°è ½Ä¹° Áö³ëŸÀÌÇÎ Àåºñ ½ÃÀå¿¡ ¹ÌÄ£ ¿µÇâÀº?
  • ½Ä¹° Áö³ëŸÀÌÇÎ Àåºñ ¼¼°è ½ÃÀå¿¡¼­ÀÇ Àåºñº° ºÐ·ù´Â?
  • ½Ä¹° Áö³ëŸÀÌÇÎ Àåºñ ¼¼°è ½ÃÀå ¿ëµµº° ºÐ·ù´Â?
  • ½Ä¹° Áö³ëŸÀÌÇÎ Àåºñ ¼¼°è ½ÃÀåÀº ÃÖÁ¾ ¿ëµµ¿¡ µû¶ó ¾î¶»°Ô ±¸ºÐµÇ´Â°¡?
  • ½Ä¹° Áö³ëŸÀÌÇÎ Àåºñ ¼¼°è ½ÃÀå¿¡¼­ ÁÖ¿ä Áö¿ªÀº?
  • ½Ä¹° Áö³ëŸÀÌÇÎ Àåºñ ¼¼°è ½ÃÀå ³» ÁÖ¿ä ±â¾÷Àº?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹üÀ§¿Í Á¶»ç ¹æ¹ý

  • Á¶»ç ¸ñÀû
  • ÀÌÇØ°ü°èÀÚ
  • µ¥ÀÌÅÍ ¼Ò½º
    • 1Â÷ Á¤º¸
    • 2Â÷ Á¤º¸
  • ½ÃÀå ÃßÁ¤
    • º¸ÅÒ¾÷ Á¢±Ù
    • Åé´Ù¿î Á¢±Ù
  • Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ¼­·Ð

  • °³¿ä
  • ÁÖ¿ä »ê¾÷ µ¿Çâ

Á¦5Àå ¼¼°èÀÇ ½Ä¹° Áö³ëŸÀÌÇÎ Àåºñ ½ÃÀå

  • ½ÃÀå °³¿ä
  • ½ÃÀå ½ÇÀû
  • COVID-19ÀÇ ¿µÇâ
  • ½ÃÀå ¿¹Ãø

Á¦6Àå ½ÃÀå ºÐ¼® : Àåºñº°

  • SNP Áö³ëŸÀÌÇÎ Àåºñ
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • ½Ç½Ã°£ PCR ±â±â
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • DNA ¾Ö³Î¶óÀÌÀú
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • ¾×ü 󸮱â
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • ±âŸ
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø

Á¦7Àå ½ÃÀå ºÐ¼® : ¿ëµµº°

  • ½Ä¹° ¿¬±¸
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • À°Á¾
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • Á¦Ç° °³¹ß
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • ǰÁú Æò°¡
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø

Á¦8Àå ½ÃÀå ºÐ¼® : ÃÖÁ¾ ¿ëµµº°

  • ¿Â½Ç
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • ¹ç
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • ½ÇÇè½Ç
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø

Á¦9Àå ½ÃÀå ºÐ¼® : Áö¿ªº°

  • ºÏ¹Ì
    • ¹Ì±¹
      • ½ÃÀå µ¿Çâ
      • ½ÃÀå ¿¹Ãø
    • ij³ª´Ù
      • ½ÃÀå µ¿Çâ
      • ½ÃÀå ¿¹Ãø
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
      • ½ÃÀå µ¿Çâ
      • ½ÃÀå ¿¹Ãø
    • ÀϺ»
      • ½ÃÀå µ¿Çâ
      • ½ÃÀå ¿¹Ãø
    • Àεµ
      • ½ÃÀå µ¿Çâ
      • ½ÃÀå ¿¹Ãø
    • Çѱ¹
      • ½ÃÀå µ¿Çâ
      • ½ÃÀå ¿¹Ãø
    • È£ÁÖ
      • ½ÃÀå µ¿Çâ
      • ½ÃÀå ¿¹Ãø
    • Àεµ³×½Ã¾Æ
      • ½ÃÀå µ¿Çâ
      • ½ÃÀå ¿¹Ãø
    • ±âŸ
      • ½ÃÀå µ¿Çâ
      • ½ÃÀå ¿¹Ãø
  • À¯·´
    • µ¶ÀÏ
      • ½ÃÀå µ¿Çâ
      • ½ÃÀå ¿¹Ãø
    • ÇÁ¶û½º
      • ½ÃÀå µ¿Çâ
      • ½ÃÀå ¿¹Ãø
    • ¿µ±¹
      • ½ÃÀå µ¿Çâ
      • ½ÃÀå ¿¹Ãø
    • ÀÌÅ»¸®¾Æ
      • ½ÃÀå µ¿Çâ
      • ½ÃÀå ¿¹Ãø
    • ½ºÆäÀÎ
      • ½ÃÀå µ¿Çâ
      • ½ÃÀå ¿¹Ãø
    • ·¯½Ã¾Æ
      • ½ÃÀå µ¿Çâ
      • ½ÃÀå ¿¹Ãø
    • ±âŸ
      • ½ÃÀå µ¿Çâ
      • ½ÃÀå ¿¹Ãø
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
      • ½ÃÀå µ¿Çâ
      • ½ÃÀå ¿¹Ãø
    • ¸ß½ÃÄÚ
      • ½ÃÀå µ¿Çâ
      • ½ÃÀå ¿¹Ãø
    • ±âŸ
      • ½ÃÀå µ¿Çâ
      • ½ÃÀå ¿¹Ãø
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ³»¿ª : ±¹°¡º°
    • ½ÃÀå ¿¹Ãø

Á¦10Àå SWOT ºÐ¼®

  • °³¿ä
  • °­Á¡
  • ¾àÁ¡
  • ±âȸ
  • À§Çù

Á¦11Àå ¹ë·ùüÀÎ ºÐ¼®

Á¦12Àå PorterÀÇ Five Forces ºÐ¼®

  • °³¿ä
  • ¹ÙÀ̾îÀÇ ±³¼··Â
  • °ø±Þ ±â¾÷ÀÇ ±³¼··Â
  • °æÀï Á¤µµ
  • ½Å±Ô ÁøÃâ¾÷üÀÇ À§Çù
  • ´ëüǰÀÇ À§Çù

Á¦13Àå °¡°Ý ºÐ¼®

Á¦14Àå °æÀï ±¸µµ

  • ½ÃÀå ±¸Á¶
  • ÁÖ¿ä ±â¾÷
  • ÁÖ¿ä ±â¾÷ °³¿ä
    • Agilent Technologies Inc.
    • BGI Genomics
    • Eurofins Scientific
    • Evogene Ltd.
    • Illumina Inc.
    • LGC Biosearch Technologies
    • Merck KgaA
    • Oxford Nanopore Technologies Limited
    • PerkinElmer Inc.
    • Promega Corporation
    • Thermo Fisher Scientific
LSH 23.11.24

Abstract

The global plant genotyping equipment market size reached US$ 686 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 1,203 Million by 2028, exhibiting a growth rate (CAGR) of 9.8% during 2022-2028. The rising demand for high yielding crops, increasing need to improve the tolerance and adaptability of plants, and the thriving agriculture industry represent some of the key factors driving the market.

Plant genotyping is the process of identifying the differences in genetic comprehension by analyzing the deoxyribonucleic acid (DNA) sequence with a sample or reference. It relies on next-generation sequencing (NGS) technology to develop plants with high nutritional content and resistance to illnesses and environmental stress. It assists in studying the diversity and evolution of different species, germplasm characterization and seed purity, and marker-assisted selection (MAS). It is used in various fields of agricultural research, such as crop trait development and seed quality control. It can be achieved through various equipment, such as single nucleotide polymorphism (SNP) genotyping equipment, real-time polymerase chain reaction (PCR) instruments, DNA analyzer, and liquid handler. Plant genotyping equipment is used to analyze, identify, and assess genetic markers in the plant. It also promotes crop yield by changing or integrating the genes of plants at the molecular level and during the breeding process.

Plant Genotyping Equipment Market Trends:

At present, there is a rise in the demand for high-yielding crops due to the growing population across the globe. This, along with the thriving agriculture industry, represents one of the key factors supporting the growth of the market. Moreover, the increasing need to improve the tolerance and adaptability of plants to various adverse environments for assuring stable and higher crop production is propelling the growth of the market. Besides this, the growing demand for plant genotyping equipment to understand the genetic characteristics associated with complex plant traits and the effects of various environmental factors on these traits is positively influencing the market. In addition, there is an increase in the utilization of plant genotyping equipment to identify variants associated with desired phenotypic traits around the world. This, coupled with the rising adoption of modern farming practices, is offering lucrative growth opportunities to industry investors. Apart from this, the escalating demand for plant genotyping equipment to understand the genotype behavior of plants, such as yield, tolerance, and resistance against biotic and abiotic stress, is strengthening the growth of the market. Additionally, the growing demand for SNP genotyping equipment and quantitative trait locus (QTL) for enhancing various plant characteristics, such as high pest resistance, more yield, and improved stress tolerance, is offering a favorable market outlook.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global plant genotyping equipment market report, along with forecasts at the global, regional and country levels from 2023-2028. Our report has categorized the market based on equipment, application and end use.

Equipment Insights:

SNP Genotyping Equipment

Real-time PCR Instrument

DNA Analyzer

Liquid Handler

Others

The report has provided a detailed breakup and analysis of the plant genotyping equipment market based on the equipment type. This includes SNP genotyping equipment, real-time PCR instrument, DNA analyzer, liquid handler, and others. According to the report, SNP genotyping equipment represented the largest segment.

Application Insights:

Plant Research

Breeding

Product Development

Quality Assessment

A detailed breakup and analysis of the plant genotyping equipment market based on the application has also been provided in the report. This includes plant research, breeding, product development, and quality assessment. According to the report, breeding accounted for the largest market share.

End Use Insights:

Greenhouse

Field

Laboratory

A detailed breakup and analysis of the plant genotyping equipment market based on the end use has also been provided in the report. This includes greenhouse, field, and laboratory. According to the report, laboratory accounted for the largest market share.

Regional Insights:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, Europe was the largest market for plant genotyping equipment. Some of the factors driving the Europe plant genotyping equipment market included the growing research and development (R&D) activities in agriculture, development of advanced plant genotyping equipment, increasing food security concerns, etc.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global plant genotyping equipment market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Agilent Technologies Inc., BGI Genomics, Eurofins Scientific, Evogene Ltd., Illumina Inc., LGC Biosearch Technologies, Merck KgaA, Oxford Nanopore Technologies Limited, PerkinElmer Inc., Promega Corporation, Thermo Fisher Scientific, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report

  • 1. What was the size of the global plant genotyping equipment market in 2022?
  • 2. What is the expected growth rate of the global plant genotyping equipment market during 2023-2028?
  • 3. What are the key factors driving the global plant genotyping equipment market?
  • 4. What has been the impact of COVID-19 on the global plant genotyping equipment market?
  • 5. What is the breakup of the global plant genotyping equipment market based on the equipment?
  • 6. What is the breakup of the global plant genotyping equipment market based on the application?
  • 7. What is the breakup of the global plant genotyping equipment market based on the end use?
  • 8. What are the key regions in the global plant genotyping equipment market?
  • 9. Who are the key players/companies in the global plant genotyping equipment market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Plant Genotyping Equipment Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Equipment

  • 6.1 SNP Genotyping Equipment
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Real-time PCR Instrument
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 DNA Analyzer
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Liquid Handler
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Others
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Plant Research
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Breeding
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Product Development
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Quality Assessment
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by End Use

  • 8.1 Greenhouse
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Field
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Laboratory
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Agilent Technologies Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 BGI Genomics
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
    • 14.3.3 Eurofins Scientific
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Evogene Ltd.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
    • 14.3.5 Illumina Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 LGC Biosearch Technologies
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 Merck KgaA
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Oxford Nanopore Technologies Limited
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 SWOT Analysis
    • 14.3.9 PerkinElmer Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Promega Corporation
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 Thermo Fisher Scientific
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦